Press release
direct/ Eureko B.V. (NL) - Eureko to Sell Part of F&C Shareholding to Focus on Core Markets
Eureko B.V., which currently has approximately a 19.6% shareholding in F&C Asset Management plc, has today announced that it intends to sell up to 44 million ordinary shares, which represents approximately 9.1% of the outstanding F&C share capital. The disposal is driven by Eureko´s strategic focus on its development in Central/Eastern Europe, and a decision to re-allocate some of its capital to further expansion in those markets. Specifically, it will use some of the capital realised from the sale of F&C shares to partially fund the recently-announced acquisition of insurance businesses in Turkey, from Garanti Bank.Eureko´s relationship with, and strategic commitment to, F&C will be unaltered; there will be no change to the investment management contracts with Eureko Group companies, which are subject to long-term mandates. These mandates run at least until 2014 and operate well. Eureko remains a key investor in F&C and is currently its second-largest shareholder.
In addition to the on-going long term contract with F&C, Eureko intends to retain its seat on the Board of F&C. Further, there will be a lock-up of 12 months for the remaining F&C shares retained by Eureko, subject to certain exceptions. Eureko is strongly supportive of F&C´s recently adopted three-year growth plan.
F&C will participate in a roadshow to market the offer which, if successful in full, upon completion, will result in an increased F&C free-float. The twin benefits for F&C are that the core shareholder structure remains in place, and that there will be improved liquidity, giving an opportunity to broaden F&C´s investor base.
Ends
Zeist
17 May 2007
Morgan Stanley is acting as adviser and book runner to Eureko on the transaction.
For further information, contact,
At Eureko:
Lorrie Morgan (Intl media)
Tel: +31 30 693 7065
Mobile: +31 654 93 72 72
Marco Simmers (Dutch media)
Mobile: +31 653 43 87 18
Barth Scholten (Investor Relations)
Tel: +31 30 693 7051
At F&C:
Jason Hollands:
Tel: +44 20 7011 4168
Mobile: +44 7768 661 382
This announcement has been issued by Eureko and is the sole responsibility of Eureko.
Morgan Stanley & Co. International plc is acting for Eureko and no-one else in connection with the placing of the F&C shares and will not be responsible to anyone other than Eureko for providing the protections afforded to its clients nor for providing advice in relation to the placing or any other matter referred to in this announcement.
This announcement is for information purposes only and does not constitute an offer or an invitation to acquire or dispose of any securities or investment advice in any jurisdiction.
This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for securities in the United States, Australia, Canada or Japan or to US Persons, (as defined under Regulation S of the US Securities Act of 1933) or to Australian, Canadian or Japanese Persons or any jurisdiction in which such offer or solicitation is unlawful.
This announcement is not for publication or distribution or release in the United States. The shares in F&C Asset Management plc referred to in this announcement have not been, and will not be, registered under the US Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offering of the securities referred to in this announcement in the United States.
pdf version press release
http://hugin.info/133916/R/1127472/209651.pdf
The announcement distributed by directnews.
The issuer is solely responsible for the content of this announcement.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release direct/ Eureko B.V. (NL) - Eureko to Sell Part of F&C Shareholding to Focus on Core Markets here
News-ID: 20652 • Views: …
More Releases from Eureko B.V.
THOMAS VAN RIJCKEVORSEL APPOINTED TO EUREKO EXECUTIVE BOARD
Zeist, 14 March 2008 - The Supervisory Board of Eureko has decided to appoint Mr. T.C.A.M. (Thomas) van Rijckevorsel to the Executive Board of Eureko effective 1 April 2008. He is currently a member of the Rabobank Private Clients Directorate.
Van Rijckevorsel (53) joined ABN AMRO after graduating with a law degree from Leiden University. He then transferred to Rabobank in 1991. From 1994 his responsibilities were extended to include…
direct/ Eureko B.V. (NL) - EUREKO / ACHMEA AND AGIS ZORGVERZEKERINGEN MERGER FIN …
Zeist/Amersfoort, 28 December 2007 - The merger of Eureko and Agis Zorgverzekeringen is a fact. The Councils of Members of Vereniging Achmea and Vereniging Agis have given the green light to the merger. The external supervisors, the Netherlands Competition Authority (NMa) and the Nederlandsche Bank (DNB) have given their approval. The merger creates the largest health insurance group in the Netherlands, insuring a total of 4.7 million people.
Agis will…
direct/ Eureko B.V. (NL) - Eureko Announces 2007 Interim Results
Net profit on course, strong premium growth
Expansion in Turkey and merger with Agis announced
- Net profit on course at EUR 561 million; down 16% from EUR 669 million at 30 June 2006
- Gross written premiums up 9% to EUR 8,602 million, from EUR 7,910 million in the first half of 2006
- Value of new business (life insurance) up to EUR 33 million, from EUR 23 million…
Eureko increases its stake in BCP
Eureko B.V. announced today that it has acquired a further 2.72% stake in Banco Comercial Português, SA (\"BCP\"), bringing the total shareholding of the Eureko Group in BCP to 9.96%.
This transaction emphasizes Eureko´s long-standing strategic partnership with BCP.
Ends
Zeist, 9 July 2007
For further information, contact:
Lorrie Morgan (International media)
Tel: +31 (0)30 693 7065 Mobile: +31 (0)654 93 72 72
Marco Simmers (Dutch media)
Tel: +31 (0) 653…
More Releases for F&C
Twelve Strings Guitar Market | C. F. Martin & Company, Cort Guitars, ESP, Fender …
Introduction:
The introduction to the report serves as a gateway into the comprehensive world of the twelve strings guitar market. As industries continue to evolve and adapt to changing consumer demands and technological advancements, understanding the market dynamics becomes paramount for industry stakeholders. The report takes on the responsibility of offering a profound and all-encompassing analysis of the twelve strings guitar market, catering to the needs of a diverse audience that…
Exponential Rise In Vitamin C Consumption Driving Preference For Ascorbic Acid W …
Persistence Market Research has published a new research study titled "Ascorbic Acid: Global Industry Analysis 2013-2017 and Forecast 2018-2028". According to PMR analysis, the global Ascorbic Acid market that was valued at US$ 997.3 Mn at the end of 2017 will reach beyond US$ 1,700 Mn by the end of 2028, at a healthy CAGR of 5.1% over 2018-2028. Rampant population growth has been leading to global increase in…
Jewelry Making Supplies Market is Gaining Momentum by key players F&C Jewelry, K …
The Latest research study released by HTF MI “Global Jewelry Making Supplies Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this…
Integrated Risk Management Software Market Aims to Expand at Double-Digit Growth …
This Integrated Risk Management Software market report tries to give some independent information in order to protect the money of firms. It contains information on market share, market strategies, growth drivers, and the impact of the COVID-19 epidemic on small and large enterprises, as well as the impact of COVID-19 on every industry. It looks at potential investment possibilities in light of the present market scenario. Sellers, purchasers, and consumers…
Hepatitis C Treatment Market 2024 | F Hoffmann-La Roche Ltd, Bristol-Myers Squib …
Demand for Hepatitis C Treatment Expected to Remain High in North America during 2016-2024
According to a recent study conducted by RRI, the global market for hepatitis C treatment is expected to expand at a CAGR of over 13% during the forecast period (2016-2024). By the end of 2016, market is anticipated to stand at US$ 26.6 and is estimated to surpass US$ 71 Billion by 2024.
Factors such as higher per…
Licorice Root Market Sees Outstanding Growth in Future| Leading Players- Norevo, …
Latest research study from HTF MI with title Global Licorice Root by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type, application/end-users. The research study provides estimates for Global Licorice Root Forecast till 2023.
If…